1. Home
  2. PBM vs REVB Comparison

PBM vs REVB Comparison

Compare PBM & REVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBM
  • REVB
  • Stock Information
  • Founded
  • PBM 1994
  • REVB 2020
  • Country
  • PBM Canada
  • REVB United States
  • Employees
  • PBM N/A
  • REVB N/A
  • Industry
  • PBM
  • REVB Biotechnology: Pharmaceutical Preparations
  • Sector
  • PBM
  • REVB Health Care
  • Exchange
  • PBM NYSE
  • REVB Nasdaq
  • Market Cap
  • PBM 3.5M
  • REVB 3.8M
  • IPO Year
  • PBM N/A
  • REVB N/A
  • Fundamental
  • Price
  • PBM $11.50
  • REVB $2.88
  • Analyst Decision
  • PBM
  • REVB
  • Analyst Count
  • PBM 0
  • REVB 0
  • Target Price
  • PBM N/A
  • REVB N/A
  • AVG Volume (30 Days)
  • PBM 82.6K
  • REVB 269.2K
  • Earning Date
  • PBM 08-05-2025
  • REVB 08-08-2025
  • Dividend Yield
  • PBM N/A
  • REVB N/A
  • EPS Growth
  • PBM N/A
  • REVB N/A
  • EPS
  • PBM 41.77
  • REVB N/A
  • Revenue
  • PBM N/A
  • REVB N/A
  • Revenue This Year
  • PBM N/A
  • REVB N/A
  • Revenue Next Year
  • PBM N/A
  • REVB N/A
  • P/E Ratio
  • PBM $0.28
  • REVB N/A
  • Revenue Growth
  • PBM N/A
  • REVB N/A
  • 52 Week Low
  • PBM $2.93
  • REVB $2.11
  • 52 Week High
  • PBM $701.82
  • REVB $168.00
  • Technical
  • Relative Strength Index (RSI)
  • PBM 87.02
  • REVB 44.79
  • Support Level
  • PBM $5.05
  • REVB $2.97
  • Resistance Level
  • PBM $5.60
  • REVB $3.18
  • Average True Range (ATR)
  • PBM 1.01
  • REVB 0.23
  • MACD
  • PBM 0.63
  • REVB 0.13
  • Stochastic Oscillator
  • PBM 93.15
  • REVB 60.37

About PBM PSYENCE BIOMEDICAL LTD

Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

Share on Social Networks: